李嘉诚罕见出手。近日,上市公司和黄医药发布公告,宣布以6.08亿美元(约合人民币45亿元)现金向上海金浦健服股权投资管理有限公司(简称“金浦健服投资管理”)和上海医药集团股份有限公司(简称“上海医药”)出售其在上海和黄药业有限公司(简称“和黄药业”)的45%的股权。时间回到2001年,李嘉诚所掌舵的和黄医药联手上海医药成立上海和黄药业,开启“中药梦“。20年一晃而过,这一笔投资无疑带来丰厚回报。在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.